Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? (Q31818207)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1 reference

Europe PubMed Central

Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

O'Keefe JH

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Wetzel M

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Moe RR

3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Bronsnahan K

4

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Lavie CJ

5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1-8

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the adverse cardiovascular prognosis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibition in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The renin-angiotensin-aldosterone system: a specific target for hypertension management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance and thrombosis: a cardiologist's view

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

How to use ACE-inhibitors, beta-blockers, and newer therapies in AMI.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Is high blood pressure a late manifestation of the hypertension syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901044-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(00)01044-5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31818207&oldid=1641062548"